IM Cannabis (IMCC) to Release Quarterly Earnings on Thursday

IM Cannabis (NASDAQ:IMCCGet Free Report) will issue its quarterly earnings data before the market opens on Thursday, November 14th. Analysts expect the company to announce earnings of ($1.03) per share for the quarter.

IM Cannabis (NASDAQ:IMCCGet Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.17) EPS for the quarter, beating analysts’ consensus estimates of ($0.84) by $0.67. IM Cannabis had a negative net margin of 26.46% and a negative return on equity of 97.26%. The firm had revenue of $10.78 million for the quarter, compared to analysts’ expectations of $9.62 million. On average, analysts expect IM Cannabis to post $-6 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

IM Cannabis Price Performance

Shares of NASDAQ IMCC opened at $1.97 on Thursday. IM Cannabis has a fifty-two week low of $1.13 and a fifty-two week high of $8.10. The company has a 50 day simple moving average of $2.21 and a two-hundred day simple moving average of $2.85. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.52 and a current ratio of 0.69. The company has a market capitalization of $4.39 million, a price-to-earnings ratio of -0.48 and a beta of 0.45.

IM Cannabis Company Profile

(Get Free Report)

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands.

Read More

Earnings History for IM Cannabis (NASDAQ:IMCC)

Receive News & Ratings for IM Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IM Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.